
New Patient Guidelines Released for Breast Cancer Screening and Diagnosis
The new guidelines offer patients advice on when they should start their screening, and how often they should have it done.
The new guidelines offer patients advice on when they should start their screening, and how often they should have it done.
A recent study shows that most patients who underwent such screening were diagnosed at an earlier stage than those who did not.
For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.
The American Society for Gastrointestinal Endoscopy releases new recommendations for screening those with genetic susceptibility.
From - Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…